l9n/ Connecticut

2026 Regular Session

Senate Bill 451

AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES.

In the Senate since March 5, 2026.

What it does

The synopsis the General Assembly published with the bill.

To establish an advisory council on access to chimeric antigen receptor T-cell therapy and other gene therapies for the treatment of cancer.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Martha Marx

Its course

March 5 to April 9, 2026, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action9 actions on 6 days

In the SenateFrom Mar 5

Public Health CommitteeMar 5 to Mar 2318 days

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the Senate Mar 5 – Mar 23

  1. Mar 5Introduced and sent to Public Health Committee
  2. Mar 9Heard in Public Health Committee
  3. Mar 23Public Health Committee recommended it
All 9 actions, as published
  1. Mar 5REF. TO JOINT COMM. ONBoth houses
  2. Mar 9PUBLIC HEARINGBoth houses
  3. Mar 23Joint FavorableBoth houses
  4. Mar 24FILED WITH LCOBoth houses
  5. Apr 2REFERRED TO OLR, OFABoth houses
  6. Apr 9RPTD. OUT OF LCOBoth houses
  7. Apr 9FAV. RPT., TAB. FOR CAL., SEN.Senate
  8. Apr 9SENATE CALENDAR NUMBERSenate
  9. Apr 9FILE NO.Both houses